Diamedica Therapeutics Stock Volatility

DMAC Stock  USD 4.34  0.05  1.17%   
DiaMedica Therapeutics appears to be slightly risky, given 3 months investment horizon. DiaMedica Therapeutics secures Sharpe Ratio (or Efficiency) of 0.12, which denotes the company had a 0.12% return per unit of standard deviation over the last 3 months. We have found thirty technical indicators for DiaMedica Therapeutics, which you can use to evaluate the volatility of the firm. Please utilize DiaMedica Therapeutics' Semi Deviation of 2.68, mean deviation of 2.67, and Downside Deviation of 2.95 to check if our risk estimates are consistent with your expectations. Key indicators related to DiaMedica Therapeutics' volatility include:
90 Days Market Risk
Chance Of Distress
90 Days Economic Sensitivity
DiaMedica Therapeutics Stock volatility depicts how high the prices fluctuate around the mean (or its average) price. In other words, it is a statistical measure of the distribution of DiaMedica daily returns, and it is calculated using variance and standard deviation. We also use DiaMedica's beta, its sensitivity to the market, as well as its odds of financial distress to provide a more practical estimation of DiaMedica Therapeutics volatility.
  

ESG Sustainability

While most ESG disclosures are voluntary, DiaMedica Therapeutics' sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to DiaMedica Therapeutics' managers and investors.
Environmental
Governance
Social
Since volatility provides investors with entry points to take advantage of stock prices, companies, such as DiaMedica Therapeutics can benefit from it. Downward market volatility can be a perfect environment for investors who play the long game as hey may decide to buy additional stocks of DiaMedica Therapeutics at lower prices to lower their average cost per share. Similarly, when the prices of DiaMedica Therapeutics' stock rise, investors can sell out and invest the proceeds in other equities with better opportunities.

Moving together with DiaMedica Stock

  0.61A Agilent Technologies Fiscal Year End 18th of November 2024 PairCorr
  0.75BMY Bristol Myers SquibbPairCorr
  0.63JNJ Johnson Johnson Fiscal Year End 28th of January 2025 PairCorr

Moving against DiaMedica Stock

  0.91INAB In8bio IncPairCorr
  0.85ONCT Oncternal TherapeuticsPairCorr
  0.84INKT Mink TherapeuticsPairCorr
  0.84NXTC NextCurePairCorr
  0.79ERNA Eterna TherapeuticsPairCorr
  0.79MOLN Molecular PartnersPairCorr
  0.74MBIO Mustang BioPairCorr
  0.73MNMD Mind MedicinePairCorr
  0.72DYAI Dyadic InternationalPairCorr

DiaMedica Therapeutics Market Sensitivity And Downside Risk

DiaMedica Therapeutics' beta coefficient measures the volatility of DiaMedica stock compared to the systematic risk of the entire market represented by your selected benchmark. In mathematical terms, beta represents the slope of the line through a regression of data points where each of these points represents DiaMedica stock's returns against your selected market. In other words, DiaMedica Therapeutics's beta of -0.59 provides an investor with an approximation of how much risk DiaMedica Therapeutics stock can potentially add to one of your existing portfolios. DiaMedica Therapeutics currently demonstrates below-average downside deviation. It has Information Ratio of 0.12 and Jensen Alpha of 0.53. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure DiaMedica Therapeutics' stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact DiaMedica Therapeutics' stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.
3 Months Beta |Analyze DiaMedica Therapeutics Demand Trend
Check current 90 days DiaMedica Therapeutics correlation with market (Dow Jones Industrial)

DiaMedica Beta

    
  -0.59  
DiaMedica standard deviation measures the daily dispersion of prices over your selected time horizon relative to its mean. A typical volatile entity has a high standard deviation, while the deviation of a stable instrument is usually low. As a downside, the standard deviation calculates all uncertainty as risk, even when it is in your favor, such as above-average returns.

Standard Deviation

    
  3.25  
It is essential to understand the difference between upside risk (as represented by DiaMedica Therapeutics's standard deviation) and the downside risk, which can be measured by semi-deviation or downside deviation of DiaMedica Therapeutics' daily returns or price. Since the actual investment returns on holding a position in diamedica stock tend to have a non-normal distribution, there will be different probabilities for losses than for gains. The likelihood of losses is reflected in the downside risk of an investment in DiaMedica Therapeutics.

DiaMedica Therapeutics Stock Volatility Analysis

Volatility refers to the frequency at which DiaMedica Therapeutics stock price increases or decreases within a specified period. These fluctuations usually indicate the level of risk that's associated with DiaMedica Therapeutics' price changes. Investors will then calculate the volatility of DiaMedica Therapeutics' stock to predict their future moves. A stock that has erratic price changes quickly hits new highs, and lows are considered highly volatile. A stock with relatively stable price changes has low volatility. A highly volatile stock is riskier, but the risk cuts both ways. Investing in highly volatile security can either be highly successful, or you may experience significant failure. There are two main types of DiaMedica Therapeutics' volatility:

Historical Volatility

This type of stock volatility measures DiaMedica Therapeutics' fluctuations based on previous trends. It's commonly used to predict DiaMedica Therapeutics' future behavior based on its past. However, it cannot conclusively determine the future direction of the stock.

Implied Volatility

This type of volatility provides a positive outlook on future price fluctuations for DiaMedica Therapeutics' current market price. This means that the stock will return to its initially predicted market price. This type of volatility can be derived from derivative instruments written on DiaMedica Therapeutics' to be redeemed at a future date.
Transformation
The output start index for this execution was zero with a total number of output elements of sixty-one. DiaMedica Therapeutics Average Price is the average of the sum of open, high, low and close daily prices of a bar. It can be used to smooth an indicator that normally takes just the closing price as input.

DiaMedica Therapeutics Projected Return Density Against Market

Given the investment horizon of 90 days DiaMedica Therapeutics has a beta of -0.5886 suggesting as returns on the benchmark increase, returns on holding DiaMedica Therapeutics are expected to decrease at a much lower rate. During a bear market, however, DiaMedica Therapeutics is likely to outperform the market.
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to DiaMedica Therapeutics or Biotechnology sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that DiaMedica Therapeutics' price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a DiaMedica stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
DiaMedica Therapeutics has an alpha of 0.5305, implying that it can generate a 0.53 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta).
   Predicted Return Density   
       Returns  
DiaMedica Therapeutics' volatility is measured either by using standard deviation or beta. Standard deviation will reflect the average amount of how diamedica stock's price will differ from the mean after some time.To get its calculation, you should first determine the mean price during the specified period then subtract that from each price point.

What Drives a DiaMedica Therapeutics Price Volatility?

Several factors can influence a stock's market volatility:

Industry

Specific events can influence volatility within a particular industry. For instance, a significant weather upheaval in a crucial oil-production site may cause oil prices to increase in the oil sector. The direct result will be the rise in the stock price of oil distribution companies. Similarly, any government regulation in a specific industry could negatively influence stock prices due to increased regulations on compliance that may impact the company's future earnings and growth.

Political and Economic environment

When governments make significant decisions regarding trade agreements, policies, and legislation regarding specific industries, they will influence stock prices. Everything from speeches to elections may influence investors, who can directly influence the stock prices in any particular industry. The prevailing economic situation also plays a significant role in stock prices. When the economy is doing well, investors will have a positive reaction and hence, better stock prices and vice versa.

The Company's Performance

Sometimes volatility will only affect an individual company. For example, a revolutionary product launch or strong earnings report may attract many investors to purchase the company. This positive attention will raise the company's stock price. In contrast, product recalls and data breaches may negatively influence a company's stock prices.

DiaMedica Therapeutics Stock Risk Measures

Given the investment horizon of 90 days the coefficient of variation of DiaMedica Therapeutics is 837.6. The daily returns are distributed with a variance of 10.54 and standard deviation of 3.25. The mean deviation of DiaMedica Therapeutics is currently at 2.59. For similar time horizon, the selected benchmark (Dow Jones Industrial) has volatility of 0.79
α
Alpha over Dow Jones
0.53
β
Beta against Dow Jones-0.59
σ
Overall volatility
3.25
Ir
Information ratio 0.12

DiaMedica Therapeutics Stock Return Volatility

DiaMedica Therapeutics historical daily return volatility represents how much of DiaMedica Therapeutics stock's daily returns swing around its mean - it is a statistical measure of its dispersion of returns. The firm inherits 3.247% risk (volatility on return distribution) over the 90 days horizon. By contrast, Dow Jones Industrial accepts 0.7835% volatility on return distribution over the 90 days horizon.
 Performance 
       Timeline  

About DiaMedica Therapeutics Volatility

Volatility is a rate at which the price of DiaMedica Therapeutics or any other equity instrument increases or decreases for a given set of returns. It is measured by calculating the standard deviation of the annualized returns over a given period of time and shows the range to which the price of DiaMedica Therapeutics may increase or decrease. In other words, similar to DiaMedica's beta indicator, it measures the risk of DiaMedica Therapeutics and helps estimate the fluctuations that may happen in a short period of time. So if prices of DiaMedica Therapeutics fluctuate rapidly in a short time span, it is termed to have high volatility, and if it swings slowly in a more extended period, it is understood to have low volatility.
Please read more on our technical analysis page.
Last ReportedProjected for Next Year
Selling And Marketing Expenses27 K24 K
Market Cap37.6 M32.3 M
DiaMedica Therapeutics' stock volatility refers to the amount of uncertainty or risk involved with the size of changes in its stock's price. It is a statistical measure of the dispersion of returns on DiaMedica Stock over a specified period of time, often expressed as the standard deviation of daily returns. In other words, it measures how much DiaMedica Therapeutics' price varies over time.

3 ways to utilize DiaMedica Therapeutics' volatility to invest better

Higher DiaMedica Therapeutics' stock volatility means that the price of its stock is changing rapidly and unpredictably, while lower stock volatility indicates that the price of DiaMedica Therapeutics stock is relatively stable. Investors and traders use stock volatility as an indicator of risk and potential reward, as stocks with higher volatility can offer the potential for more significant returns but also come with a greater risk of losses. DiaMedica Therapeutics stock volatility can provide helpful information for making investment decisions in the following ways:
  • Measuring Risk: Volatility can be used as a measure of risk, which can help you determine the potential fluctuations in the value of DiaMedica Therapeutics investment. A higher volatility means higher risk and potentially larger changes in value.
  • Identifying Opportunities: High volatility in DiaMedica Therapeutics' stock can indicate that there is potential for significant price movements, either up or down, which could present investment opportunities.
  • Diversification: Understanding how the volatility of DiaMedica Therapeutics' stock relates to your other investments can help you create a well-diversified portfolio of assets with varying levels of risk.
Remember it's essential to remember that stock volatility is just one of many factors to consider when making investment decisions, and it should be used in conjunction with other fundamental and technical analysis tools.

DiaMedica Therapeutics Investment Opportunity

DiaMedica Therapeutics has a volatility of 3.25 and is 4.17 times more volatile than Dow Jones Industrial. 28 percent of all equities and portfolios are less risky than DiaMedica Therapeutics. You can use DiaMedica Therapeutics to enhance the returns of your portfolios. The stock experiences a large bullish trend. Check odds of DiaMedica Therapeutics to be traded at $4.77 in 90 days.

Good diversification

The correlation between DiaMedica Therapeutics and DJI is -0.14 (i.e., Good diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding DiaMedica Therapeutics and DJI in the same portfolio, assuming nothing else is changed.

DiaMedica Therapeutics Additional Risk Indicators

The analysis of DiaMedica Therapeutics' secondary risk indicators is one of the essential steps in making a buy or sell decision. The process involves identifying the amount of risk involved in DiaMedica Therapeutics' investment and either accepting that risk or mitigating it. Along with some common measures of DiaMedica Therapeutics stock's risk such as standard deviation, beta, or value at risk, we also provide a set of secondary indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential stocks, we recommend comparing similar stocks with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.

DiaMedica Therapeutics Suggested Diversification Pairs

Pair trading is one of the very effective strategies used by professional day traders and hedge funds capitalizing on short-time and mid-term market inefficiencies. The approach is based on the fact that the ratio of prices of two correlating shares is long-term stable and oscillates around the average value. If the correlation ratio comes outside the common area, you can speculate with a high success rate that the ratio will return to the mean value and collect a profit.
The effect of pair diversification on risk is to reduce it, but we should note this doesn't apply to all risk types. When we trade pairs against DiaMedica Therapeutics as a counterpart, there is always some inherent risk that will never be diversified away no matter what. This volatility limits the effect of tactical diversification using pair trading. DiaMedica Therapeutics' systematic risk is the inherent uncertainty of the entire market, and therefore cannot be mitigated even by pair-trading it against the equity that is not highly correlated to it. On the other hand, DiaMedica Therapeutics' unsystematic risk describes the types of risk that we can protect against, at least to some degree, by selecting a matching pair that is not perfectly correlated to DiaMedica Therapeutics.

Complementary Tools for DiaMedica Stock analysis

When running DiaMedica Therapeutics' price analysis, check to measure DiaMedica Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy DiaMedica Therapeutics is operating at the current time. Most of DiaMedica Therapeutics' value examination focuses on studying past and present price action to predict the probability of DiaMedica Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move DiaMedica Therapeutics' price. Additionally, you may evaluate how the addition of DiaMedica Therapeutics to your portfolios can decrease your overall portfolio volatility.
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
FinTech Suite
Use AI to screen and filter profitable investment opportunities